Michels, S., & Provencio Pulla, M. (2024). Overall survival and central nervous system activity of crizotinib in ROS1-rearranged lung cancer—final results of the EUCROSS trial.
Citación estilo ChicagoMichels, S., y Mariano Provencio Pulla. Overall Survival and Central Nervous System Activity of Crizotinib in ROS1-rearranged Lung Cancer—final Results of the EUCROSS Trial. 2024.
Cita MLAMichels, S., y Mariano Provencio Pulla. Overall Survival and Central Nervous System Activity of Crizotinib in ROS1-rearranged Lung Cancer—final Results of the EUCROSS Trial. 2024.
Precaución: Estas citas no son 100% exactas.